4 out of 10 cancer cases could be prevented with lifestyle changes
A vaccine-like cancer treatment successfully treated 97 percent of the mice in one study. Human clinical trials are scheduled to start later this year and begin an "exciting" phase in cancer history. Adalberto Roque )
A vaccine-like anti-cancer treatment successfully removes 97 percent of tumors in mice, although its transfer to human pathology still has a long way to go.
Stanford University researchers tested a promising remedy for cancer in mice by stimulating the immune system to attack cancer cells. The mice have been diagnosed with lymphoma, breast and colon cancer and these cancer cells have finally spread throughout their bodies.
87 out of 90 mice were cured of their cancers, giving a 97 percent success rate. [1
Dr. Alice Alice Police, Regional Head of Breast Surgery at the Northwell Health Cancer Institute in Westchester, New York, said these findings represent an "exciting" development in the field of cancer research. She emphasized, however, that animal results in humans may not give the same results.
She added that cancer in mice has long been treated for years, so the next step should definitely be human clinical trials. 19659004] Dr. med. Ronald Levy, a professor at Stanford University, said 35 patients were diagnosed with lymphoma to take part in two studies later this year.
The researchers also found that the upcoming human studies on lymphoma patients only do not necessarily apply to breast or colon cancer patients
Immunotherapy versus chemotherapy, CAR-T
The American Society of Clinical Oncology has developed A cancer vaccine that helps prevent cancer cells from occurring simultaneously destroys all malignant cells in the body.
This new treatment, published in the journal Science Translational Medicine is a type of immunotherapy. By injecting the spa into the body, two special agents begin to reactivate T cells to recognize abnormal cancer cells. Once the T cells have recognized sick cells, they will attack cancer cells and infiltrate them until nothing is left.
"Fighting the immune system against cancer is one of the latest developments in cancer, and people need to know that's in the early days, and we're still looking for security and trying to make it as good as possible," he said Levy.
Dr. Michelle Hermiston, head of the program for pediatric immunotherapy at UCSF, said immunotherapy is currently the most preferred method of treating cancer compared to other invasive therapies such as chemotherapy. Immunotherapy is also preferable to CAR-T, which requires millions of dollars and intensive work.
© 2018 Tech Times, All Rights Reserved. Do not reproduce without permission.